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j Abstract Human hydrocephalus
is a common medical condition
that is characterized by abnormal-
ities in the ﬂow or resorption of
cerebrospinalﬂuid(CSF),resulting
in ventricular dilatation. Human
hydrocephalus can be classiﬁed
into two clinical forms, congenital
and acquired. Hydrocephalus is
one of the complex and multifac-
torial neurological disorders.
A growing body of evidence
indicates that genetic factors play a
major role in the pathogenesis of
hydrocephalus. An understanding
of the genetic components and
mechanism of this complex disor-
dermayofferussigniﬁcantinsights
into the molecular etiology of
impaired brain development and
an accumulation of the cerebro-
spinal ﬂuid in cerebral compart-
ments during the pathogenesis of
hydrocephalus. Genetic studies in
animalmodelshavestartedtoopen
the way for understanding the
underlying pathology of hydro-
cephalus. At least 43 mutants/loci
linked to hereditaryhydrocephalus
have been identiﬁed in animal
models and humans. To date, 9
genes associated with hydrocepha-
lus have been identiﬁed in animal
models. In contrast, only one such
gene has been identiﬁed in hu-
mans. Most of the known hydro-
cephalus gene products are the
important cytokines, growth fac-
tors or related molecules in the
cellular signal pathways during
early brain development. The cur-
rent molecular genetic evidence
from animal models indicates that
in the early development stage,
impaired and abnormal brain
development caused by abnormal
cellular signaling and functioning,
all these cellular and developmen-
tal events would eventually lead to
the congenital hydrocephalus.
Owing to our very primitive
knowledge of the genetics and
molecular pathogenesis of human
hydrocephalus, it is difﬁcult to
evaluate whether data gained from
animal models can be extrapolated
to humans. Initiation of a large
population genetics study in hu-
mans will certainly provide
invaluable information about the
molecular and cellular etiology
and the developmental mecha-
nisms of human hydrocephalus.
This review summarizes the
recent ﬁndings on this issue
among human and animal models,
especially with reference to the
molecular genetics, pathological,
physiological and cellular studies,
and identiﬁes future research
directions.
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Human hydrocephalus is a signiﬁcant medical con-
dition with an estimated incidence of 1 in 1500 births
[1]. Hydrocephalus is characterized by abnormalities
in the ﬂow or resorption of cerebrospinal ﬂuid (CSF),
resulting in ventricular dilatation. However, hydro-
cephalus is far more complicated than a simple dis-
order of CSF circulation [2]. Although commonly
considered a single disorder, human hydrocephalus is
a collection of a heterogeneous complex and multi-
factorial disorders [3]. Genetic factors are involved in
the pathogenesis of hydrocephalus [4–6]. For the
purposes of this review, we categorize hydrocephalus
as congenital, which is present at birth and often
associated with developmental defects; and acquired,
which occurs after development of the brain and
ventricles [7–12].
The development and progression of congenital
hydrocephalus is a dynamic process that is not yet
well understood. It is thought that it may develop at
an important and speciﬁc embryonic time period of
neural stem cell proliferation and differentiation in
the brain [13, 14]. Congenital hydrocephalus may
occur alone (non-syndromic) or as part of a syn-
drome with other anomalies (syndromic) [15, 16]. In
syndromic forms, it is hard to deﬁne the defective
gene because of the association with other anomalies.
We will mainly focus on isolated forms of hydro-
cephalus. In genetic terms, the isolated (non-syndro-
mic) form of hydrocephalus is a primary and major
phenotype caused by a speciﬁc faulty gene.
It is estimated that about 40% of hydrocephalus
cases have a possible genetic etiology [10]. In humans,
X-linked hydrocephalus (HSAS1, OMIM) comprises
approximately 5–15% of the congenital cases with a
genetic cause [10, 17–20]. Although there is strong
evidence for genetic causes, only one hydrocephalus
gene (X-linked) has been identiﬁed in humans.
Besidesgeneticfactors,manyotherfactorsinﬂuence
the development of congenital hydrocephalus, such as
congenital malformations, intracerebral hemorrhage,
maternal alcohol use [21, 22], infection [6, 23–25], and
X-ray radiation during pregnancy [26, 27].
Genetics in hydrocephalus
Congenital hydrocephalus is the more common of the
two forms of hydrocephalus, and is probably the
consequence of abnormal brain development and
perturbed cellular function, which emphasizes the
important roles that congenital hydrocephalus genes
play during brain development. In general, the
recurrence risk for congenital hydrocephalus
excluding X-linked hydrocephalus is low. Empiric risk
rates range from <1% to 4% [28–30], indicating the
rarity of autosomal recessive congenital hydrocepha-
lus [10, 20, 31, 32]. However, multiple human kin-
dreds with congenital hydrocephalus have been
reported [10, 15, 20, 32–43]. The loci or genes for
human autosomal recessive congenital hydrocephalus
have not yet been identiﬁed, but there is at least one
locus for this trait. Furthermore, like animal models,
since there is heterogeneity among clinical pheno-
types, there may be more genetic loci in human
autosomal recessive congenital hydrocephalus.
One kindred was reported in which congenital
hydrocephalus was transmitted in an autosomal
dominant fashion. This condition was associated
with aqueductal stenosis but was not associated
with mental retardation or pyramidal tract dys-
function. The lack of mental retardation and pyra-
midal tract dysfunction was in contrast to X-linked
or recessive congenital hydrocephalus with stenosis
of the aqueduct of Sylvius (HSAS), in which these
abnormalities are commonly seen [44]. Another
study identiﬁed a kindred with a microdeletion of
8q12.2-q21.2 which subsequently developed hydro-
cephalus. This trait was also transmitted in an
autosomal dominant fashion [45]. Molecular genetic
studies have revealed that the responsible gene for
X-linked human congenital hydrocephalus is at
Xq28 encoding for L1CAM (L1 protein) [46]. The
mutations are distributed over the functional pro-
tein domains. The exact mechanisms by which these
mutations cause a loss of L1 protein function are
still under investigation.
Another form of this disorder, acquired or adult-
onset hydrocephalus is mostly sporadic and charac-
terized by ventricular enlargement in the absence of
signiﬁcant elevations of intracranial pressure; there-
fore this form is termed normal pressure hydro-
cephalus (NPH). Deﬁnite changes in CSF ﬂow,
resorption, and associated dynamics have been found
in NPH patients, and these changes may represent a
pathogenic mechanism or a secondary phenomenon
[47]. Adult-onset hydrocephalus may develop either
as a result of decompensation of a ‘‘compensated’’
congenital hydrocephalus, or it may arise de novo in
adult life secondary to an acquired disturbance of
normal CSF dynamics. The latter may be due to late-
onset aqueductal stenosis or disruption of normal
CSF absorptive pathways [11, 48]. Acquired (adult-
onset, or NPH) form of inherited hydrocephalus is
very rare. Recently, an X-linked adult-onset NPH [49]
and a form of familial NPH that is transmitted in
autosomal dominant fashion [50] have been reported,
but detailed genetic linkage studies have not been
carried out yet. The genetic etiology of this form is
therefore totally unknown.
1256Hydrocephalus has been observed in many mam-
mals [51–59]. Animal hydrocephalus models have
many histopathological similarities to humans and
can be used to understand the genetics and patho-
genesis of brain damage [59–64]. It has been well
documented in the animal models that in the majority
of cases, congenital hydrocephalus is a genetic dis-
ease. Furthermore, many congenital hydrocephalus
loci have been mapped and identiﬁed in the animal
models.
Hydrocephalic Texas strain (HTX) rat model of
inherited congenital hydrocephalus is characterized
by onset in late gestation, a complex mode of inher-
itance, and ventricular dilatation associated with
abnormalities in the cerebral aqueduct and subcom-
missural organ (SCO), a structure that is important
for the patency of the aqueduct of Sylvius and normal
CSF ﬂow in the brain. Quantitative trait locus (QTL)
genetic mapping has been performed from the prog-
eny of a backcross of HTX rat with the non-hydro-
cephalic Fischer F344 strain. The disease has been
linked with loci on chromosome (Chr) 9 (peak
markers D9Rat2), 10 (between markers D10Rat136
and D10Rat135), 11 (peak markers D11Arb2 and
D11Rat46) and 17 (peak markers D17mit4 and
D17Rat154) respectively. The severity of hydroceph-
alus in HTX rat seems to be inﬂuenced by different
genetic loci [65–68]. Another study suggested that the
HTX strain is homozygous carrier of an autosomal
recessive hydrocephalus gene with incomplete pene-
trance [69]. The genetics of another hydrocephalus
inbred strain, Wistar-Lewis rats (LEW/Jms) which
demonstrate inherited congenital hydrocephalus, is
less clear with possible traits as an autosomal reces-
sive [70] or semidominant or multigenic (possible
QTL) with a possible locus on sex chromosomes [71],
but none of the loci has been localized.
In mouse models, three QTL loci associated with
congenital hydrocephalus have been identiﬁed and
labeled as Vent8a, Vent4b, and Vent7c. As a major
QTL controlling variance in ventricular size, Vent8a is
located on Chr 8 (near the markers D8Mit94 and
D8Mit189). The Other two loci, Vent4b and Vent7c,
show strong epistatic interactions affecting ventricu-
lar size in the developing embryo. Vent4b is located
on Chr 4 (near D4Mit237 and D4Mit214), and Vent7c
is located on Chr 7 (between D7Mit178 and
D7Mit191) [72].
The autosomal recessive congenital hydrocepha-
lus-1 (hy1) mouse has been characterized phenotyp-
ically by a dome-shaped head that is sometimes seen
at birth or develops during the ﬁrst 2 weeks. Inter-
nally, dilatation of the entire ventricular system is
observed [73,74]. A more severe phenotypic form,
hydrocephalus-2 (hy2) mouse [75, 76], and an
obstructive hydrocephalus (oh) mouse with commu-
nicating hydrocephalus and secondary aqueductal
stenosis have also been described [77, 78]. Unfortu-
nately subsequent efforts to identify genetic loci have
not been done on these non-inbred mouse strains.
In mouse targeted insertional mutagenesis, the
accidental insertion of a transgene into a crucial
genomic locus could yield important information,
which has happened twice in hydrocephalus genetic
studies. The transgenic mouse line OVE459 demon-
strates autosomal recessive congenital hydrocephalus.
This is caused by a Bdnf transgene-induced insertional
mutation on a single locus on mouse Chromosome 8
(near marker D8Mit152). The OVE459 insertion locus
is overlapped with that of autosomal recessive
hydrocephalus-3 (hy3) mouse that phenotypically
shows lethal communicating hydrocephalus with
perinatal onset [79, 80]. The transgene insertion re-
sulted as a rearrangement of Hydin exons in OVE459
mice. Subsequently, a single CG base-pair deletion in
exon 15 of Hydin was also discovered in hy3 mice
carrying the spontaneous hy3 mutant allele [81, 82].
In another targeted insertional mutagenesis
resulting in congenital hydrocephalus, the CYP2J2
transgene interferes with the expression of a brain-
speciﬁc isoform of the regulatory factor X4 (RFX4),
which belongs to the winged helix transcription factor
family. This brain speciﬁc isoform is called variant
transcript 3 or RFX4_v3 and is crucial for normal
brain development as well as for the genesis of the
SCO. Loss of a single allele prevents formation of the
SCO and leads to an autosomal dominant congenital
hydrocephalus. This obstructive hydrocephalus ap-
peared to be secondary to failure of development of
the SCO [83].
The autosomal recessive congenital hydrocephalus
(ch) mouse was reported decades ago [79]. Recently
this mouse has been shown to have a mutation on
another winged helix/forkhead transcription factor
gene, Foxc1 (Mf1) on mouse Chromosome 13 [84, 85].
There is a recent report of 6 children with hydro-
cephalus from 3 different families with subtelomeric
deletions from chromosome 6p. Three forkhead genes
within this region (FOXF1 and FOXQ1) or proximal
to it (FOXC1) were evaluated as potential candidate
disease genes but no disease causing mutations were
identiﬁed [86].
The autosomal recessive hydrocephalus with hop
gait (hyh) mouse exhibits dramatic dilation of the
ventricles at birth and invariably develops hopping
gait. The hyh mouse shows a markedly small cerebral
cortex at birth and dies postnatally from progressive
enlargement of the ventricular system. The small
cortex in hyh mouse reﬂects altered development of
the neuronal cells. In this mouse, it is postulated that
neural progenitor cells withdraw prematurely from
the cell cycle, producing more early-born, deep-layer
1257cerebral cortical neurons but depleting the cortical
progenitor pool, and creating a small cortex. Genetic
linkage analysis localized the hyh locus between
markers D7Mit75 and D7Mit56 on mouse Chr 7. La-
ter, the hyh gene was identiﬁed as a-SNAP (soluble
NSF attachment protein a)[ 87]. Homozygous mutant
mice harbor a missense mutation M105I in a con-
served residue in one of the a-helical domains. The
hyh mutant was not a null allele and is expressed;
however, the mutant protein is 40% less abundant in
hyh mice.
The autosomal recessive hemorrhagic hydroceph-
alus (hhy) homozygous mutant mouse has dilated
lateral ventricles and a patent aqueduct, with no his-
tological abnormalities either in the subarachnoid
space or in the choroid plexus. Multiple hemorrhages
in the meninges and throughout the brain paren-
chyma can be observed in the advanced stages of
hydrocephalus. The hhy locus has been localized on
mouse Chr 12 [88].
Recently, several new congenital hydrocephalus
models have emerged in zebra ﬁsh mutagenesis
screening. These models have been shown to have the
defects in embryogenesis and early development
leading to enlarged brain ventricles. However, genetic
loci for these models have not been identiﬁed yet [89,
90].
Genetic studies in animal models have started to
open the way for understanding the underlying
pathology of hydrocephalus. In contrast to research
with animal models, human hydrocephalus genetic
research has lagged far behind. To date, at least 43
mutants of hydrocephalus have been described, and
10 congenital hydrocephalus genes have been identi-
ﬁed. Among them, only one hydrocephalus gene has
been identiﬁed in humans (see Table 1).
Developmental, physiological and anatomical
pathology of hydrocephalus
The neuropathology of hydrocephalus has been ade-
quately elucidated. Cerebral ventricle dilatation sec-
ondary to disturbed CSF ﬂow has been observed as an
inheritable trait in a variety of laboratory animals (as
well as in humans). In most cases, defective devel-
opment of the cerebral aqueduct or the subarachnoid
space has been observed [61]. Affected individuals
may have severe developmental delay and radio-
graphic ﬁndings of hydrocephalus [91].
The morphological and developmental changes
in the ventricular system have been well studied in
three major rat models of congenital hydrocephalus:
6-aminonicotinamide (6-AN)-induced, LEW/Jms and
HTX mutant rats. Comparative morphological stud-
ies revealed that 6-AN-induced hydrocephalus was
comparable to the Dandy-Walker syndrome. The
LEW/Jms and HTX mutant models were identical
with regard to the form of presentation and pro-
gression of hydrocephalus in the postnatal period;
but the pathogenesis of these two conditions in the
fetal period was different. The LEW/Jms rats showed
primary congenital aqueductal stenosis in early
prenatal life and the hydrocephalic state appeared
before pulmonary maturation was completed. How-
ever, although the model has been considered to be
of congenital communicating hydrocephalus [64],
the HTX fetuses demonstrated secondary closure of
the aqueduct in the perinatal period. This secondary
closure of the aqueduct in HTX rats is believed to be
due to retrograde degeneration of the thalamus
caused by apoptotic cell death [92, 93] and failure in
cell proliferation [94, 95]. The HTX rat also shows a
reduction in the secretory cells of the SCO.
Regarding the role of the SCO in hydrocephalus
pathogenesis, serial brain sections through aqueduct
regions containing the SCO from HTX rats, in
comparison with normal Fischer F344 strain, have
been studied and found that reduced SCO glyco-
protein immunoreactivity precedes both aqueduct
closure and expansion of the lateral ventricles in the
HTX rate (as it’s redundant) [96, 97].
Although some studies have addressed the activa-
tion of macrophages and microglia (the resident
mononuclear phagocytes of the brain) within the
brain in animal hydrocephalus models, little is known
of their state of activation or regional distribution in
human congenital hydrocephalus. In one experiment,
brain tissue samples of 10 human fetal cases with
hydrocephalus and 10 non-hydrocephalic controls
were stained immunohistochemically with antibodies
directed against MHC class II and CD68 antigens, and
lectin histochemistry was done with tomato lectin.
Hydrocephalus cases showed focal collections of
CD68 and tomato lectin-positive macrophages along
the ependymal lining of the lateral ventricles, partic-
ularly within the occipital horn. By comparison, brain
tissue samples from controls showed few or no
ependymal or supraependymal macrophages and the
few macrophages that were present were not as in-
tensely immunoreactive as in the hydrocephalus
cases. The macrophage response detected at the
ependymal lining of the ventricles and within the
periventricular area in hydrocephalus may be related
both to the severity of hydrocephalus and the age of
the fetus [98]. Microglia that are normally inter-
spersed throughout the intermediate zone and cir-
cumscribing the basal ganglia were within normal
conﬁnes in all cases examined. Unexpectedly, hydro-
cephalic cases also showed focal regions of hypovas-
cularization or alterations in the structure and
1258orientation of capillaries within periventricular areas,
compared with controls [98].
In summary, the pathological studies of hydro-
cephalus clearly indicate that impaired and abnormal
brain development in the early development stage
caused by altered neural cell fate and perturbed reg-
ulation of cellular proliferation and apoptosis. The
abnormal brain development subsequently leads to
the accumulation of the CSF in cerebral cavities. All
these cellular and developmental events eventually
lead to the congenital hydrocephalus accompanied by
possible secondary inﬂammatory reaction and neu-
rovascular pathogenesis.
The molecular and cellular etiology of
hydrocephalus
One of the possible mechanisms leading to the path-
ogenesis of hydrocephalus is the disruption of neural
cell membrane proteins that play an important func-
tion during brain development. The L1 protein coded
by human X-linked hydrocephalus gene is a member
of the immunoglobulin superfamily of neural cell
adhesion molecules that is expressed in neurons and
Schwann cells, and seems to be essential for the brain
development and function. Hirschsprung’s disease
Table 1 Summary of current known loci (or mutants) of hydrocephalus in vertebrates
Species Strain Clinical form Trait* Locus Chromosome Human syntenic region Human Gene References
Human C AR Unknown unknown 10,15,27,32–43
Human C AD Unknown 8q12.2–21.2 or unknown 44,45
Human AO AD NPH unknown 50
Human C X-linked L1cam X X L1CAM 46
Human AO X-linked Unknown X X 49
Rat HTX C QTL D9Rat2 9q38 5q21.1, 18p11.22–31 65–68
Rat HTX C QTL D10Rat136, D10Rat135 10q32.1–10q32.3 17q21.3–q25.3 65–68
Rat HTX C QTL D11Arb2, D11Rat46 11q23 3q27–28, 22q11.21,10p12.2 65–68
Rat HTX C QTL D17Mit4, D17Rat154 17q12.1 1q43, 10p11.21–p13 65–68
Rat LEW/Jms C AR, (QTL) unknown unknown 70,71
Mouse C57BL/6J C QTL Vent8a 8 8p11–23, 13q11–34 72
Mouse C57BL/6J C QTL Vent4b 4 6p, 9 72
Mouse C57BL/6J C QTL Vent7c 7 19q10–13 72
Mouse hy1 C AR unknown unknown 73,74
Mouse hy2 C AR unknown unknown 75,76
Mouse hy3 C AR Hydin 8 16q22.2 HYDIN 79–82
Mouse C57BL/10J C AR hyh 7 19q13.3 a-SNAP 87, 100
Mouse C57BL6/J C AD Rfx4 10 12q24 RFX4 83
Mouse BALB/cHeA C AR hhy 12 14q32 88
Mouse ch C AR Mf1 13 6p25 FREAC-3 84
Mouse STOCK tb C AR oh unknown 77,78
Mouse C57BL/6*CBA/J C AR Mdnah5 15 5p15.2 DNAH5 106
Mouse C57BL/CBA C AD Otx2 14 14q21-q22 OTX2 122
Mouse 129P2/OlaHsd C AR Msx1 5 4p16.3-p16.1 MSX1 107,108
Mouse C57BL/6 C AR Socs7 11 17q12 SOCS7 118
Mouse C57BL/6J C AR Nmhc-b 11 17q13 MYH10 121
Zebrafish m404/m491 C AR apo unknown 89,90
Zebrafish m409/m432 C AR cudak unknown 89,90
Zebrafish m691 C AR eagle unknown 89,90
Zebrafish m591 C AR endeavor unknown 89,90
Zebrafish m584 C AR enterprise unknown 89,90
Zebrafish m492/m510 C AR galileo unknown 89,90
Zebrafish m445/m585/m700 C AR gumowy unknown 89,90
Zebrafish m727 C AR hubble unknown 89,90
Zebrafish m221/m470/m680 C AR interrail unknown 89,90
Zebrafish m733 C AR kepler unknown 89,90
Zebrafish m728 C AR neil unknown 89,90
Zebrafish m481 C AR pan twardowski unknown 89,90
Zebrafish m172/m476 C AR uchu hikoushi unknown 89,90
Zebrafish m766 C AR voyager unknown 89,90
Zebrafish m331 C AR viking unknown 89,90
Zebrafish m479/m627 C AR yura unknown 89,90
Zebrafish m111/m307/m512/m97 C AR zezem unknown 89,90
* Genetic trait, AR: autosomal recessive, AD:autosomal dominant, QTL: Quantitative trait locus, ** clinicalform, C: congenital, AO: Adut-Onset
1259(HSCR) is characterized by the absence of ganglion
cells and the presence of hypertrophic nerve trunks in
the distal bowel. There have been several reports of
patients with X-linked hydrocephalus and HSCR with
a mutation in the L1CAM gene. Therefore, decreased
L1CAM may also be a modifying factor in the
development of HSCR [99].
The gene carrying the mutation for autosomal
recessive hydrocephalus in the hyh mouse codes a-
SNAP protein. a-SNAP is essential for apical protein
localization and cell fate determination in neuroepi-
thelial cells [100]. a-SNAP plays a key role in a wide
variety of membrane fusion events in eukaryotic cells.
Membrane fusion is required for two main cellular
functions: 1) the transport of molecules to distinct
inter- and intracellular compartments and thereby
maintenance of the functional and structural organi-
zation of eukaryotic cells; 2) the intercellular com-
munication such as the regulated exocytosis
(secretion) of neurotransmitters by neuronal cell,
which occurs temporally and spatially as the precise
sequential regulation events at the plasma membrane
during the early brain development [87]. In the hyh
mouse model, altered neural cell fate is also accom-
panied by abnormal localization of many apical pro-
teins implicated in regulation of neural cell fate,
including E-cadherin, beta-catenin, atypical protein
kinase C (aPKC), inactivation-no-afterpotential D-like
(INADL), SNAP receptor (SNARE), and vesicle-asso-
ciated membrane protein-7 (VAMP-7) [100]. Fur-
thermore, disturbed astrocyte metabolism in the early
brain development in the kaolin-induced rat model of
hydrocephalus has also been reported [101].
Hydrocephalus may also be caused by a malfunc-
tion of the ependymal cells [102–105]. Within the
neonatal brain of the mouse, the hy3 protein (hydin)
is conﬁned to the ciliated ependymal cell layer lining
the lateral, third and fourth ventricles. Hydin is not
closely related to any previously known protein, with
the exception of a 314 amino acid domain with
homology to caldesmon, an actin-binding protein,
suggesting that hydin interacts with the cytoskeleton
[81, 82]. The protein of axonemal heavy chain 5 gene
(Mdnah5), dynein is also speciﬁcally expressed in
ependymal cells, and is essential for ultra structural
and functional integrity of ependymal cilia. In
Mdnah5-mutant mice, lack of ependymal ﬂow causes
closure of the aqueduct and subsequent formation of
triventricular hydrocephalus during early postnatal
brain development. The higher incidence of aqu-
eductal stenosis and hydrocephalus formation in pa-
tients with ciliary defects proves the relevance of this
novel mechanism in humans [106].
Hydrocephalus may be caused by malfunction of
mesenchymal cells. In mice, Msx1 is a regulatory gene
involved in epithelio-mesenchymal interactions in
limb formation and organogenesis. In the embryonic
brain, the Msx1 gene is expressed along the dorsal
midline. The most important features observed in
homozygous Msx1 mutants were the absence or
malformation of the posterior commissure (PC) and
of the SCO, the collapse of the cerebral aqueduct, and
the development of hydrocephalus. The heterozygous
mutants developed an abnormal PC and smaller SCO,
as revealed by speciﬁc antibodies against SCO secre-
tory glycoproteins. About one third of the heterozy-
gous mutants also developed hydrocephalus;
therefore the phenotype may be determined by the
Msx1 gene dosage during a speciﬁc developmental
period [107, 108]. In the autosomal recessive con-
genital hydrocephalus (ch) mouse model, a truncated
protein lacking the DNA-binding domain of the
forkhead/winged helix gene, Mf1, was generated.
Mesenchymal cells from Mf1lacZ embryos differenti-
ate poorly into cartilage in micromass culture and do
not respond to added bone morphogenetic protein 2
(BMP2) and transforming growth factor-beta 1
(TGFB1). The differentiation of arachnoid cells in
meninges of the mutant mice is also abnormal. The
levels of developmental growth factors such as TGFB1
and BMP2 are dramatically increased in the ch mouse,
and it is possible that phenotypic hydrocephalus of
Mf1 mouse is due to the secondary effect of these
elevated growth factors. Corresponding to studies in
the ch mouse, human patients with deletions in the
region containing human Mf1 homolog FREAC3 were
found to develop multiple developmental disorders,
including hydrocephalus [84]. Another winged helix
transcription factor causing congenital hydrocephalus
when mutated, RFX4_v3 transcript, is dynamically
expressed in the developing brain from the neural
plate stages. The RFX proteins belong to the winged-
helix subfamily of helix-turn-helix transcription fac-
tors, and bind to  X-boxes’ in target DNA sequences
and regulate expression of the downstream target
genes [83]. Disruption of both RFX4_v3 alleles by
insertional mutagenesis severely alters early brain
morphogenesis, reduces Msx2 expression, and causes
a deﬁciency in WNT signaling [83]. This may suggest
that RFX4_v3 is probably upstream of Mf1 in the
signaling pathway during early brain development.
Hydrocephalus may be caused by perturbation of
growth factor signaling [109, 110]. Developmental
abnormalities in congenital hydrocephalus provide
the clues for the perturbation of major signaling
pathways in the development [111]. TGFB is an
important cytokine and growth-signaling molecule in
the brain. In mouse models, severe hydrocephalus has
been observed in transgenic mouse overexpression of
TGFB1 in astrocytes [112, 113]. In the HTX rat, in-
creased level of TGFB3 may contribute to the devel-
opment of hydrocephalus [114]. In mouse models,
1260ﬁbroblast growth factor-2 (FGF-2) seems to play a
predominant role in the proliferation of neuronal
precursors and in neuronal differentiation in the
developing cerebral cortex even at relatively late stages
of brain neurogenesis. Administration of FGF-2 to
embryonic brain induces hydrocephalic brain mor-
phology and aberrant differentiation of neurons in the
postnatal cerebral cortex [110]. IGF binding protein-1
(IGFBP-1) modulates the cellular action of insulin-like
growth factors (IGFs), some of which are expressed in
the fetal brain. Hydrocephalus has been observed in
mouse models that overexpress liver-speciﬁc IGFBP-1
during fetal life. The hepatic over-expression of IG-
FBP-1 may have endocrine effects on brain develop-
ment and induction of congenital hydrocephalus
[115]. Other studies have shown that up-regulation of
certain growth factors in the brain could lead to al-
tered brain ﬂuid dynamics [116, 117]. SOCS7 is a
member of the suppressor of cytokine signaling
(SOCS) protein family. SOCS proteins have a similar
structure: an N-terminal domain of variable length, a
central Src homology-2 domain, and a C-terminal
SOCS box. Biochemical and genetic studies have re-
vealed that SOCS family members play an important
role in the termination of cytokine and growth factor
signaling. Homozygous Socs7 mutant mice were born
in expected numbers, were fertile, and did not exhibit
defects in hematopoiesis or circulating glucose or
insulin concentrations. Strikingly however, these
homozygous Socs7 mice were 7–10% smaller than
their wild-type littermates, and within 15 weeks of age
approximately 50% of the homozygous Socs7 mice
died as a result of hydrocephalus. In situ hybridization
studies in normal mice have revealed that Socs7 is
prominently expressed in the brain, suggesting that
SOCS7 plays an important functional role in early
brain development [118]. We can therefore hypothe-
size that loss of SOCS7 function will lead to increased
expression of cytokines resulting in developmental
abnormalities and congenital hydrocephalus due to its
inhibitory role in cytokine signaling.
Hydrocephalus may also be caused by the disrup-
tion of extracellular matrix (ECM). In the TGFB1
over-expression mouse model, the changing expres-
sions of a remodeling protein - matrix metallopro-
teinase-9 (MMP-9) and its speciﬁc inhibitor- tissue
inhibitor of metalloproteinases-1 (TIMP-1) were also
found to be important factors in the spontaneous
development of hydrocephalus by altering the ECM
environment [119]. Furthermore, increased expres-
sion of cytokines such as TGFB1 might also recipro-
cally play an important role by disrupting the vascular
ECM remodeling, promoting hemorrhages, and
altering the re-absorption of CSF [120]. In another
mouse model, ablation of the nonmuscle myosin
heavy chain II-B (NMHC-B) results in severe hydro-
cephalus with enlargement of the lateral and third
ventricles. These defects may be caused by abnor-
malities in the cell adhesive properties of neuroepi-
thelial cells and suggest that NMHC-B is essential for
both early and late developmental processes in the
mammalian brain [121].
Hydrocephalus may also be caused by the disrup-
tion of major early brain developmental patterning
molecules. Autosomal dominant hydrocephalus in
Otx2 mutation mice is characterized by eminent
dilatation of lateral ventricles and a ballooned cere-
brum. Histopathology shows edematous change of the
periventricular white matter, suggesting that Otx2
functions as a brain developmental organizer, and a
disruption of this gene is a likely cause of
hydrocephalus [122].
In conclusion, many genetic loci of hydrocephalus
have been deﬁned in animal models, which is building
a foundation for better understanding of molecular
etiology of hydrocephalus; however, genetic research
of hydrocephalus in humans is limited. The histo-
pathological similarities of animal models can be used
to understand the genetics and pathogenesis of hu-
man hydrocephalus. For example, the histopatholog-
ical and morphological appearance of hydrocephalic
HTX rats is demonstrated in Fig. 1, in which hydro-
philic HTX rat exhibits large cerebral ventricles, a
progressively-thinned cortical mantle, and stretched
internal capsule ﬁbers[123]. Review of the molecular
etiologies shows a very diverse set of pathogenetic
mechanisms. Perturbation of almost any molecule
that plays a crucial role in early brain development,
and sequentially regulation of dynamics of cerebro-
spinal ﬂuid, could lead to the pathogenesis of con-
genital hydrocephalus. The 10 known hydrocephalus
genes mostly code for important cytokines, growth
factors, or related molecules in the cellular signal
pathways during early brain development.
Future prospects
It is essential to recognize that molecular genetics is
the only current scientiﬁc approach that can be used
to study hydrocephalus in which the usual concern
about whether an observed phenomenon is a
consequence or a cause is completely addressed.
Despite our knowledge of the genetics of hydro-
cephalus in animal models, we have very limited
knowledge about the genetic and molecular mecha-
nisms that cause human hydrocephalus. Without this
knowledge, it is impossible to say whether the path-
ogenesis of human hydrocephalus is comparable
to that seen in animal models, and impractical to
extrapolate data gained from animal models to
humans. In order to better understand human
1261hydrocephalus and to develop more appropriate
translational research, it will be necessary to conduct
large-scale genetic studies of human hydrocephalus.
If, and when, more heritable forms of human hydro-
cephalus are identiﬁed, and underlying genes and
their functions are characterized, then this knowledge
could be used to improve patient care in a variety of
different ways such as prenatal diagnosis and new
potential therapeutic approaches. Possible new
mechanisms other than altered CSF circulation and
resorption, if uncovered via the genetic research, may
also help explain why patients with hydrocephalus
may experience symptomatic progression despite
functioning shunts.
Efforts to identify genetic variants associated with
susceptibility to genetic diseases rely on three major
approaches: pedigree and sib-pair linkage analysis
and population association studies. The differences
among these study designs reﬂect their derivation
from biological versus epidemiological traits. Like
most common diseases, it would be very difﬁcult to
identify and recruit large pedigrees in hydrocephalus
that show hereditary transmission of the condition.
Therefore, the last two approaches, sib-pair linkage
analysis and population association studies, are the
best options for the genetic study on this disease. For
any study, but particularly in the case of genetic
mapping for a common disease, a large sample size is
crucial in achieving statistical signiﬁcance. Recent
advances in the genomics and statistical methodology
in genetic mapping will certainly help in making well-
powered studies more feasible, by reducing the
number of genetic markers or workload required for
these studies. For example, since many genes and loci
response for hydrocephalus in animal models have
been mapped, candidate genes approach will certainly
be the very ﬁrst choice to test the collected human
hydrocephalus population for linkage and association
analysis.
In collaboration with the Hydrocephalus Associa-
tion (HA), our group has initiated a genetic study of
human hydrocephalus. As part of a prospective study
that has been approved by the Johns Hopkins Insti-
tutional Review Board, we are collecting blood sam-
ples from both congenital and acquired NPH
hydrocephalus patients. The objectives of this study
are to identify the genetic loci responsible for the
development of hydrocephalus, to examine the rela-
tionship between genotype and phenotype and to
deﬁne the functions of these genes during early
Fig. 1 Comparison of rat brain morphology by MRI and histology at 4, 11 and 21 days of age in non-hydrocephalic and hydrocephalic HTX rats. T2-weighted MRI
scans of coronal sections from a non-hydrocephalic HTX rat at the level of the thalamus at 4, 11 and 21 days (A, D, G) shows small ventricular and subarachnoid
spaces compared to an age-matched HTX littermate (B, E, H) that exhibits large cerebral ventricles, a progressively-thinned cortical mantle, and stretched internal
capsule fibers (*). Congenital closure of the cerebral aqueduct becomes life-threatening by 21 days of age. Histological sections (C, F, I) at the level of the midbrain
at the same ages demonstrate extreme thinning of the cortical mantle. MRI images are modified from Jones et al (2000) [123] with permission by Maney Publishing;
histological samples are from the doctoral thesis of Janet M. Miller, PhD
1262development. This is the ﬁrst large-scale research
study of its kind and information gained from this
study will undoubtedly provide invaluable informa-
tion concerning the developmental mechanisms of
this disease in humans. Such knowledge will hopefully
lead to the more reasonable treatment schemes, the
better diagnostic tools, and the more effective
therapeutic modalities.
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